Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

FREE BLOG Key takeaways from HBI’s 2026 oral health webinar

Earlier this week I moderated a webinar on dental deals in 2026. The webinar really showcased just how much the sector has changed over the past year and a half. Dental deal-making is no longer just about who is buying, it is about what is worth buying. Money is being spent more carefully, and buyers […]
February 19, 2026

Synlab selling Slovakian operations to Unilabs

Pan-European diagnostic labs group Synlab has exited another market. It has sold its Slovakian operations to Unilabs, another pan-European diagnostics group, as part of its strategy to “densify its network”.
February 19, 2026

Teleradiology company Medica buys Axon

Medica, the UK’s largest teleradiology company, has bought one of its smaller competitors, Axon Diagnostics. HBI caught up with Andrew Cannon, Medica’s CEO, to discuss the acquisition and Medica’s plans for the future.
February 19, 2026

Hayfin leads Alantra’s €155m CV for genomics company Health in Code

Alantra, a Spanish private equity firm focused on mid-market transactions, has closed a €155 million healthcare continuation fund to support the next phase of growth at Health in Code (HiC), a clinical genomics company it has backed since 2020. The fund was oversubscribed and led by Hayfin Capital Management, a London-headquartered lending firm, alongside other […]
February 19, 2026

Sustainable weight loss “needs behavioural change” — Lisa Tookey, CheqUp

GLP-1 weight loss drugs are now widely used in the UK, with around 2.5 million people taking them. The market has grown fast, raising questions about how safely these medications are prescribed and how much support patients receive. NHS access is still limited and varies depending on where you live. As a result, many people are choosing to go private. 
February 19, 2026

Ampersand Capital Partners buys Purna Pharmaceuticals 

Ampersand Capital Partners, a life sciences and healthcare-focused private equity firm, has acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing service provider (CDMO) for liquid and semi-solid medicines for pharmaceutical companies, from alternative investment fund manager Creafund.
February 19, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us